Zhao, Y. M., Luo, Y., Shi, J. M., Wang, S. Q., Wang, C. K., Jiang, E. L., Liang, C., Zhu, X. Y., Zhang, X. J., Meng, F. K., Jin, H., Zhao, Y. Q., Yu, J., Lai, X. Y., Liu, L. Z., Fu, H. R., Ye, Y. S., Zhang, C. X., Wang, T., Tu, L. F., Wang, X. Q., Huang, H. (2025). A first-in-class JAK/ROCK inhibitor, rovadicitinib, for glucocorticoid-refractory or -dependent chronic GVHD. Blood. https://doi.org/10.1182/blood.2024026581